Comparison of Intravenous Dexmedetomidine and Lignocaine in Reducing Hemodynamic Responses During Laryngoscopy and Endotracheal Intubation In Patients Undergoing Cardiac Surgery at Rawalpindi Institute Of Cardiology- A Randomized Controlled Trial
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
After confirming eligibility, written informed consent will be obtained by a trained team member who is not involved in assigning treatment or giving the study medication. Each participant will receive a unique study number to protect privacy. Participants will be randomly assigned to receive one of the study medications using a chance-based method.The study medication will be administered through a vein before placement of the breathing tube. Blood pressure and pulse rate will be measured before the procedure and at several time points after the breathing tube is inserted.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:
• American Society of Anesthesiologists (ASA) physical status III-IV. Patients who are at risk of cardiovascular events
Locations
Other Locations
Pakistan
Rawalpindi Institute of Cardiology
RECRUITING
Rawalpindi
Contact Information
Primary
Namrah Zujaj, MBBS
zujajnamrah20@gmail.com
+92 305 2636980
Time Frame
Start Date: 2026-05-21
Estimated Completion Date: 2026-08-21
Participants
Target number of participants: 70
Treatments
Active_comparator: Group Dexmed
Active_comparator: Group Lignocaine
Related Therapeutic Areas
Sponsors
Leads: Rawalpindi Institute of Cardiology